Search research articles
Contact Us
Filters
Showing results (91-100 of 208) with videos related to
Page
of 21
Sort By:
Ebiomedicine
|
May 8, 2024
A roadmap to precision treatments for familial pulmonary fibrosis
Killian Hurley, Mari Ozaki, Quentin Philippot, et al.
Nature Communications
|
April 7, 2019
Adjustment for index event bias in genome-wide association studies of subsequent events
Frank Dudbridge, Richard J Allen, Nuala A Sheehan, et al.
Respiratory Research
|
March 23, 2023
The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis
Katherine E Stephenson, Joanne Porte, Aoife Kelly, et al.
ERJ Open Research
|
November 30, 2022
Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography
Laura C Price, Benjamin Garfield, Chloe Bloom, et al.
The European Respiratory Journal
|
March 9, 2019
Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort
Iain Stewart, Tricia McKeever, Rebecca Braybrooke, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 20, 2020
Reply to Althuwaybi <i>et al.</i>: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
Nazia Chaudhuri, Peter M George, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 29, 2020
BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study
Philip L Molyneaux, Jonathan J Smith, Peter Saunders, et al.
The Lancet. Respiratory Medicine
|
July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Toby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
BMJ Open
|
October 27, 2025
Association between hyperglycaemia, diabetes complications and development of fibrotic conditions among people living with type 1 and type 2 diabetes in England: a retrospective cohort study using UK Clinical Resource Datalink Aurum and Hospital Episode Statistics
Georgie May Massen, Sarah Cook, Samuel T Moss, et al.
Thorax
|
April 22, 2024
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study
Olivia C Leavy, Leticia Kawano-Dourado, Iain D Stewart, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 208) with videos related to
Sort By:
Page
of 21
Ebiomedicine
|
May 8, 2024
A roadmap to precision treatments for familial pulmonary fibrosis
Killian Hurley, Mari Ozaki, Quentin Philippot, et al.
Nature Communications
|
April 7, 2019
Adjustment for index event bias in genome-wide association studies of subsequent events
Frank Dudbridge, Richard J Allen, Nuala A Sheehan, et al.
Respiratory Research
|
March 23, 2023
The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis
Katherine E Stephenson, Joanne Porte, Aoife Kelly, et al.
ERJ Open Research
|
November 30, 2022
Persistent isolated impairment of gas transfer following COVID-19 pneumonitis relates to perfusion defects on dual-energy computed tomography
Laura C Price, Benjamin Garfield, Chloe Bloom, et al.
The European Respiratory Journal
|
March 9, 2019
Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort
Iain Stewart, Tricia McKeever, Rebecca Braybrooke, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 20, 2020
Reply to Althuwaybi <i>et al.</i>: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
Nazia Chaudhuri, Peter M George, Michael Kreuter, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 29, 2020
BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study
Philip L Molyneaux, Jonathan J Smith, Peter Saunders, et al.
The Lancet. Respiratory Medicine
|
July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Toby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
BMJ Open
|
October 27, 2025
Association between hyperglycaemia, diabetes complications and development of fibrotic conditions among people living with type 1 and type 2 diabetes in England: a retrospective cohort study using UK Clinical Resource Datalink Aurum and Hospital Episode Statistics
Georgie May Massen, Sarah Cook, Samuel T Moss, et al.
Thorax
|
April 22, 2024
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study
Olivia C Leavy, Leticia Kawano-Dourado, Iain D Stewart, et al.
Page
of 21